NLV Partners is a venture capital firm that specializes in investing in early-stage technology startups. The company provides funding, mentorship, and strategic support to entrepreneurs with innovative solutions in various sectors. NLV Partners is known for its hands-on approach and extensive network within the tech industry, helping startups to scale and succeed in competitive markets.

NLV Partners

NLVP was formed in 2005, when the healthcare team spun out of the Sprout Group. The NLVP team has been built over the last two decades and managed healthcare technology portfolios in venture capital funds. We partner with companies across all phases, from startup to public offerings, as we look to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system. And we share our broad perspectives, decades of experience and deep domain expertise to help our portfolio navigate the complexity of the healthcare industry.

CRISPR Therapeutics

Deciphera Pharmaceuticals

Bellus Health

CareDx

Karyopharm Therapeutics

TigerConnect

Cogent Biosciences

ObsEva

Alector

Aptinyx

Chimerix

Dice Therapeutics

Passage Bio

Arvinas

MEI Pharma

Neuronetics

Harpoon Therapeutics

iRhythm Technologies

Iterum Therapeutics

New Leaf Venture Partners

Congratulations to New Leaf portfolio company BrightInsight for making the 2023 Deloitte Technology Fast 500! 

Congratulations to NLV portfolio company Crinetics Pharmaceuticals on an upsized financing raising $350 million!


Congratulations to NLV portfolio company Rocket Pharmaceuticals on raising $175 million! 


Congratulations to New Leaf portfolio company Bluesight (formerly Kitcheck). Bluesight received a strategic investment by Thoma Bravo. This will support Bluesight's acquisition in Medacist. We are excited to be a major stakeholder in Bluesight's next phase of growth.

https://lnkd.in/e_gMDzTx 

Congratulations to New Leaf portfolio company DICE Therapeutics on the announcement that it is being acquired by Eli Lilly and Company!

Read all about it here:
https://lnkd.in/eFqTtVuJ


msh id	COM:NLVPARTNERS
symbol	-
name	NLV Partners
homepage url	https://nlvpartners.com
country	US
sector	Financial Services & Finance
industry	Venture Capital
market	PRIVATE
employee count	16
crunchbase url	https://www.crunchbase.com/organization/new-leaf-venture-partners
linkedin url	https://www.linkedin.com/company/new-leaf-venture-partners
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

COM:NLVPARTNERS

NLV Partners

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-